CVE-2022-38056

Name: CVE-2022-38056
Creator: NVD / NIST
Published: 2023-02-16T21:15:13.697+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 5.3/10EPSS 0.15%

Last modified Jun 17, 2026

CVE-2022-38056 is a medium-severity vulnerability rated 5.3/10 on the CVSS scale. Improper neutralization in the Intel(R) EMA software before version 1.8.1.0 may allow a privileged user to potentially enable escalation of privilege via network access.. EPSS estimates a 0.15% chance of exploitation in the next 30 days.

Description

Improper neutralization in the Intel(R) EMA software before version 1.8.1.0 may allow a privileged user to potentially enable escalation of privilege via network access.

Metrics

CVSS 3.1

5.3/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

EPSS Probability

0.15%

4.3th percentile

Probability of exploitation in the next 30 days. Learn more

Affected Software

Vendor	Product	Versions
Intel	Endpoint Management Assistant	< 1.8.1.0

References

http://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00764.htmlVendor Advisory
http://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00764.htmlVendor Advisory

Timeline

Published: Feb 16, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2022-38056?

Improper neutralization in the Intel(R) EMA software before version 1.8.1.0 may allow a privileged user to potentially enable escalation of privilege via network access.

How severe is CVE-2022-38056?

CVE-2022-38056 has a CVSS score of 5.3/10 (MEDIUM severity). The EPSS model estimates a 0.15% probability of exploitation in the next 30 days.

How do I fix CVE-2022-38056?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-38056?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST